Page last updated: 2024-08-26

cilastatin and Disease Models, Animal

cilastatin has been researched along with Disease Models, Animal in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (20.00)	18.7374
1990's	6 (30.00)	18.2507
2000's	4 (20.00)	29.6817
2010's	5 (25.00)	24.3611
2020's	1 (5.00)	2.80

Authors

Authors	Studies
Ahn, BY; Babes, L; Chojnacki, AK; Choudhury, SR; Goring, KR; Hao, X; Kelly, MM; King, JC; Kopciuk, KA; Kubes, P; Lau, A; McAvoy, EF; Muruve, DA; Patel, KD; Petri, B; Rahn, JJ; Robbins, SM; Schraeder, C; Schriemer, DC; Senger, DL; Siegel, PM; Tabariès, S; Thanabalasuriar, A; Yipp, BG	1
Eiwaz, MB; Funahashi, Y; Hebert, JF; Hutchens, MP; Matsushita, K; McCormick, JA; Mori, K; Munhall, AC; Nickerson, MN; Saritas, T; Yanagita, M	1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF	1
Aranda, F; Armiger-Borràs, N; Carrasco, E; Consuegra-Fernández, M; Di Scala, M; González-Aseguinolaza, G; Lozano, F; Martínez-Florensa, M; Pachón, J; Vila, J	1
Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ	1
Blanco-Codesido, M; Camano, S; Gomez-Gomez, MM; Humanes, B; Lara, JM; Lazaro, A; Lazaro, JA; Martín-Vasallo, P; Moreno-Gordaliza, E; Ortiz, A; Tejedor, A	1
Stanojlovic, O; Stojanovic, J; Susic, V; Zivanovic, D	1
Katsube, T; Yamano, Y; Yano, Y	1
Edelstein, PH	1
Asahi, Y; Goto, M; Inoue, M; Kaji, Y; Kimura, S; Matsuda, K; Nakagawa, S; Oka, S; Sanada, M; Shimada, K	1
Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA	1
Hogaboam, CM; Kunkel, SL; Lukacs, NW; Steinhauser, ML; Strieter, RM	1
Ernst, EJ; Guglielmo, J; Hashimoto, S; Jackson, JJ; Kropp, H; Pittet, JF; Sawa, T; Wiener-Kronish, JP	1
Cristofori, P; Di Modugno, E; Ladel, CH; Lanzoni, A; Marzola, P; Nicolato, E; Sbarbati, A	1
Abe, T; Fukuoka, T; Inoue, H; Ohya, S	1
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K	1
Atkinson, AM; Teale, DM	1
Brook, I	1
Bennett, DB; Comereski, CR; Williams, PD	1
Donabedian, H; Freimer, EH	1

Reviews

1 review(s) available for cilastatin and Disease Models, Animal

Article	Year
Pathogenesis and treatment of endocarditis. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Animals; Cilastatin; Cyclopropanes; Disease Models, Animal; Endocarditis, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Thienamycins	1985

Other Studies

19 other study(ies) available for cilastatin and Disease Models, Animal

Article	Year
Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver. Cell, 2019, 08-22, Volume: 178, Issue:5 Topics: Animals; Cilastatin; Dipeptidases; Disease Models, Animal; Endotoxemia; GPI-Linked Proteins; Humans; Lipopolysaccharides; Liver; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Neutrophil Infiltration; Neutrophils; Peptides; Platelet Glycoprotein GPIb-IX Complex; Survival Rate	2019
Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice. Journal of the American Society of Nephrology : JASN, 2021, Volume: 32, Issue:10 Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Urea Nitrogen; Cilastatin; Disease Models, Animal; Endocytosis; Glomerular Filtration Rate; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Knockout; Myoglobin; Myoglobinuria; Protease Inhibitors; Rhabdomyolysis	2021
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin. PloS one, 2019, Volume: 14, Issue:2 Topics: Animals; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Stability; Drugs, Generic; Humans; Imipenem; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Therapeutic Equivalency	2019
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1 Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cecum; Cilastatin; Cilastatin, Imipenem Drug Combination; Cytokines; Dependovirus; Disease Models, Animal; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Ligation; Male; Mice; Mice, Inbred C57BL; Receptors, Scavenger; Sepsis	2017
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins	2012
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney international, 2012, Volume: 82, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Area Under Curve; Biomarkers; Blood Urea Nitrogen; Body Weight; Cell Line, Tumor; Cilastatin; Cisplatin; Creatinine; Cytoprotection; Dipeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Glomerular Filtration Rate; GPI-Linked Proteins; Kidney; Kidney Diseases; Male; Natriuresis; Oxidative Stress; Protease Inhibitors; Rats; Rats, Wistar; Swine	2012
The effects of phenytoin and phenobarbital on seizures induced by imipenem/cilastatin in rats. Acta neurologica Belgica, 2004, Volume: 104, Issue:1 Topics: Animals; Anticonvulsants; Cilastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Imipenem; Injections, Intraventricular; Male; Phenobarbital; Phenytoin; Prohibitins; Rats; Rats, Wistar; Seizures	2004
Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cilastatin; Disease Models, Animal; Doripenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Models, Biological; Thienamycins	2008
Imipenem in Legionnaires' disease. Lancet (London, England), 1984, Sep-29, Volume: 2, Issue:8405 Topics: Animals; Cilastatin; Cyclopropanes; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Guinea Pigs; Imipenem; Legionnaires' Disease; Thienamycins	1984
Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:4 Topics: Animals; Cefotiam; Cilastatin; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Imipenem; Kinetics; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus	1993
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome	1998
Multiple roles for IL-12 in a model of acute septic peritonitis. Journal of immunology (Baltimore, Md. : 1950), 1999, May-01, Volume: 162, Issue:9 Topics: Acute Disease; Animals; Cecal Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Fibrosis; Imipenem; Immune Sera; Immunization, Passive; Interferon-gamma; Interleukin-10; Interleukin-12; Intestinal Perforation; Ligation; Mice; Peritoneum; Peritonitis; Sepsis; Wound Healing	1999
Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:10 Topics: Animals; Aztreonam; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley	1999
Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection. Magma (New York, N.Y.), 1999, Volume: 9, Issue:1-2 Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cilastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Evaluation Studies as Topic; Extremities; Histological Techniques; Imipenem; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1999
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae]. The Japanese journal of antibiotics, 2001, Volume: 54, Issue:7 Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin	2001
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia. Chemotherapy, 2001, Volume: 47, Issue:6 Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins	2001
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:6 Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis	1992
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice. The Journal of infectious diseases, 1989, Volume: 160, Issue:4 Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam	1989
Animal model for evaluating the convulsive liability of beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Disease Models, Animal; Drug Combinations; gamma-Aminobutyric Acid; Imipenem; Lactams; Male; Mice; Pentylenetetrazole; Seizures; Thienamycins	1988